Showing results for "The Trial" in Physical Illness & Disease

This book is intended for the clinical researcher who is interested in designing a clinical trial and developing a protocol. It is also of value to researchers and practitioners who must critically evaluate the literature of published clinical trials and assess the merits of each trial and the implications for the care and treatment of patients. The authors use numerous examples of published clinical trials to illustrate the fundamentals.

Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career. You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doctors, safety monitors, clinical scientists and other healthcare professionals. To learn more, visit ...

Promising treatments now in more than 35,000 clinical trials could have dramatic impacts on cancer, autoimmune diseases, organ replacement, heart disease, and even aging itself. These treatments, which are saving the lives of patients in the trials, will soon be rolled to the medical community at large. The key to these breakthroughs is the use of living cells as medicine instead of traditional drugs. Research has found that our bodies are virtual treasure troves of adult cells that act as agents of remarkable healing and repair.

Behind every protocol are humans; patients, caregivers, clinicians, researchers, advocacy communities, and more. Clinical Trial Masterclasses brings innovative voices together to show how empathy, clarity, and trust create better trials and faster breakthroughs. You’ll hear lived experiences from advocacy founders, site teams, and PIs alongside the operational playbooks that make participation feasible and inclusive. Our goal is to share experience of those who innovate and progress research, making it accessible, understandable, and collaborative for everyone.

This podcast provides deep insights into the evolving landscape of clinical trials, with a strong emphasis on sustainability and innovation. We explore innovative strategies to drive sustainability and discuss the current state of sustainability in clinical trials, industry focus areas, and the impact on patients.

Karin Avila, Roberto Torres, and Taymeyah Al-Toubah welcome you to Clinical Trial Files — your window into the world of clinical research beyond the protocol. 🎙️📁We’re excited to open the files on the people, processes, and progress shaping today’s global research landscape.With over 40 years of combined experience in clinical research—and more than 15 roles spanning research coordination to executive leadership, from hands-on clinical investigations to operations oversight—we bring a wide-lens view of this dynamic field.Together, we’ve supported, managed, or influenced ...

In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?

Welcome to a podcast delving into the personal narratives within the clinical research industry. Through candid interviews, we'll learn about the personal journeys and motivations of individuals who have chosen this profession. What I like to call 'their why'.My aim is to spotlight the often overlooked heroes of clinical trials, showcasing their passion and dedication that extends beyond the spotlight of 'big Pharma.' These conversations will illuminate the heartfelt narratives of those driving advancements in medical research.This podcast is not just for industry insiders; it's for everyone ...

Cancer strikes fear in people’s hearts around globe. So the appearance of a vaccine to prevent cancer - as we are assured the human papillomavirus (HPV) vaccine will - seemed like a game-changer. Since 2006, over 80 countries have approved the vaccine, with glowing endorsements from the world’s foremost medical authorities. Bringing in over $2.5 billion in annual sales, the HPV vaccine is a pharmaceutical juggernaut. Yet scandal now engulfs it worldwide. The HPV Vaccine on Trial is a shocking tale, chronicling the global efforts to sell and compel this alleged miracle.

A clinical research technique requires the participation of every individual with their own outcome of view and perception. A diverse volunteer participant provides the right notion of exposure, harm, side effect, and failure-s uccess rate conclusion.

For years, Monsanto declared that their product Roundup, the world’s most widely used weed killer, was safe. But that all changed in 2015, when the International Agency for Research on Cancer (IARC) analyzed data from scientific studies and concluded that glyphosate, the active ingredient in Roundup, was probably carcinogenic. The Environmental Protection Agency (EPA) disagreed, other regulatory agencies got involved, and scientists clamored to understand the link between glyphosate and cancer.

Welcome to "Clinical Trials Talks: A Podcast to Get the Conversation Going." In this new podcast series, we sit down with a lupus patient who has participated in a clinical trial, her sister who serves as her advocate, and a principal investigator involved in several clinical trials. Together, they share their personal experiences, the challenges they’ve faced, and the valuable lessons they’ve learned. Whether you're thinking about joining a trial or just curious about the process, this podcast offers patient-friendly insights into clinical trials — from the perspectives of a patient, a ...

Twenty-five years ago, my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story....

This podcast is dedicated to clinical trials and clinical research. We will be discussing different hot topics and analysis of the latest developments in clinical trials in pharmaceutical and medical devices industries. We have interviews with different industry experts.New episodes will be available every 2 weeks.

A podcast about the transformations in clinical trial. As life science companies are pressured to deliver novel drugs faster, data, processes, applications, roles and change itself is changing. We speak to people in the industry that experience these transformations up close and make sense of how the pressure can become a catalyst for transformation.

In In My Hands, surgical oncologist Dr. Steven Curley shares the empowering lessons he's learned over 25 years from his cancer patients' unique stories of struggle, perseverance, and triumph. As Chief of Surgical Oncology at Baylor College of Medicine, Dr. Steven Curley has worked with cancer...

Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like ...

Join me on my journey across the clinical trial landscape. I will be accompanied by a variety of people, all experts within their field, as we seek to understand and uncover unknowns, to shape ideas, inspire innovation and ultimately to find out how we can truly move clinical trials out of the spiralling void of higher costs and lower outputs. Click on an episode below to listen.